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Cyanobacteria (blue-green algae) are a group of ancient 
prokaryotic organisms dating back between three and four 
billion years.1 They have been attributed with oxygenat-
ing the earth’s atmosphere2 but, since the anthropogenic 
euthrophication of lakes, ponds and oceans, they have 
become synonymous with water hygiene issues.3 This is 
due to the alteration of the nutrient composition of their 
habitat to one which is optimal for growth (or blooms). 
Cyanobacterial blooms may simply cause foul tastes and 
odours,4 but they can also lead to the production of toxic 
secondary metabolites poisonous to humans and animals 
upon ingestion.5 NZ has yet to suffer a human fatality, but 
the deaths of several dogs in Wellington was attributed to 
homoanatoxin-a 1 (Chart 1) from a Phormidium species.6
Although toxins are the most highly publicized cyanobac-
terial secondary metabolites, a vast array of compounds 
are produced which range in size, structure, and bioac-
tivity. Terrestrial cyanobacteria have yielded diterpenes 
such as the anti-inflammatory tolypodiol 2,7 and the anti-
microbial comnostins8 such as comnostin B 3, in addition 
to other unusual metabolites including tolyporphin A 4 (a 
porphyrin-like compound with multi-drug resistance re-
versal properties)9 and the ambiguenes, e.g. ambiguene F 
5, which are antifungal chlorinated alkaloids (Chart 1).10
The major class of secondary metabolites produced by 
cyanobacteria is that of the oligopeptides, which are syn-
thesised by non-ribosomal peptide synthetases.11 These 
can be divided into six families depending on their struc-
tural characteristics,12 namely the aeruginosins, the mi-
croginins, the anabaenopeptins, the cyanopeptolins, the 
microcystins, and the microviridins, as exemplified by 
metabolites 6-11 of Chart 2.
In the past, oligopeptides have been detected via enzyme-
linked immunosorbent assays, enzyme inhibition assays, 
or according to their toxicity.13 These assays have fo-
cused on obtaining quantitative data on the metabolites 
present, therefore the potential of these methods as dis-
covery tools is limited. Analysis by high performance 
liquid chromatography (HPLC) is hindered by a lack of 
commercially available standards14 so that time is wasted 
isolating known metabolites. Bioactivity-directed isola-
tion has proved to be very effective in the past8 but again 
limits the researcher to detecting molecules possessing a 
certain activity. More powerful still is liquid chromatog-
raphy-mass spectrometry (LC-MS). Here, one can sepa-
rate the components in a complex mixture and obtain their 
relative molecular masses. This allows one to assess the 
potential novelty of a compound according to both mass 
and elution time prior to large-scale purification and char-
acterization. Most LC-MS instruments allow for tandem 
MS that enables structural clues to be deduced and the 
identity of known molecules to be confirmed.15 However, 
separation by HPLC involves costly and time consum-
ing sample preparation and, due to long run times, high 
throughput can be cumbersome. Analysis of cyanobacte-
rial extracts by matrix assisted laser desorption ioniza-
tion-time of flight (MALDI-TOF) MS can provide com-
parable data to those from LC-MS but with far simpler 
sample preparation.
MALDI-TOF produces ions from laser irradiation of a 
sample co-crystallized with a matrix; the laser energy is 
absorbed and passed to the analyte molecules. This meth-
od of ionization predominantly produces singly protonat-
ed ions to ca. m/z = 5000, a range which encompasses the 
oligopeptides. Thus complex mixtures can be analyzed 
from a minute amount of sample without prior separation, 
and the relative molecular mass of each component pres-
ent deduced from the protonated molecular ions.16 Cyano-
bacterial extracts are assessed simply from mixing with 
the matrix, application of the mix to a target, and spectral 
recording.
The advantages described above make MALDI-TOF 
screening of cyanobacterial extracts particularly useful 
in the discovery of novel secondary metabolites. Due to 
the high sensitivity, low sample volumes, and speed of 
analysis, environmental samples can be assessed for the 
presence of novel compounds prior to culturing. Even sin-
gle cyanobacterial colonies can be analysed by suspend-
ing them directly in matrix solution.17 Novel compounds 
are easily detected using this method by comparing the 
A
rt
ic
le
*This article, originally printed in the January issue of this Journal (2008, 72, 25-28), was subject to major production errors 
with the loss of structural displays critical to its understanding. In fairness to the authors, and to you the reader, the article is 
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component masses recorded with those in an appropriate 
database. If the mass spectrometer is also equipped for 
the analysis of post source decay (PSD) species, it is then 
analogous to LC-MS with tandem MS, and the presence 
of known compounds can be confirmed from the masses 
of the fragment ions produced.
Since cyanobacterial oligopeptides are already well char-
acterized, PSD allows for partial characterization of any 
novel compounds discovered. Often the subclass of oli-
gopeptide present can be deduced by the presence of di-
agnostic fragment ions in the spectrum, e.g. the presence 
of a m/z = 135 ion (PhCH
2
CHOMe+•) is characteristic 
of 2S,3S,8S,9S-3-amino-9-methoxy-2,6,8-trimethyl-10-
phenyldeca-4E,6E-dienoic acid (Adda, 12), the unique 
amino acid found in microcystins.16 The low mass daugh-
ter ions indicate the amino acids present in the molecule, 
while those at higher mass can indicate how the amino 
acids are joined together.
Oligopeptide characterization by MALDI-TOF MS has 
been undertaken successfully in Germany. Using the 
approach described above, von Dohren and co-workers 
were able to characterize a range of oligopeptides includ-
ing aeruginosins, microginins, anabaenopeptins, and cy-
anopeptolins, whilst assessing the oligopeptide diversity 
of different cyanobacteria. They deduced structures for 
anabaenopeptin G, 7 (Chart 2) and anabaenopeptin 820 
from analysis of the PSD fragments.12,18,19
The anabaenopeptins are cyclic peptides containing six 
amino acids. Each contains a D-lysine unit that has an 
ureido bond to a carbonyl that is linked to a side-chain 
amino acid. The D-lysine also forms a secondary peptide 
bond which encloses the ring. The CO-linked side-chain 
and the ring amino acids vary as does their degree of 
amino methylation.11 There are 21 published structures 
of anabaenopeptins and these are listed in Table 1. The 
different compounds have varied biological activities 
including relaxation of norepinephrine-induced contrac-
tion,20 protein phosphatase inhibition, and protease inhibi-
tion.21-24 Like the German workers, we too have been able 
to deduce most of the structure of a new metabolite using 
MALDI-TOF MS, namely anabaenopeptin 906, 13.
An environmental sample containing cyanobacteria was 
collected from a North Island lake. The MALDI-TOF 
MS (Fig. 1) showed the presence of several known com-
pounds as well as an unknown metabolite with m/z = 907. 
The PSD spectrum of this m/z = 907 ion is shown as Fig. 
2 and the loss of 200 Da is clear. This is diagnostic for 
an anabaenopeptin possessing an arginine side-chain. The 
low mass/charge species indicate the presence of arginine 
(Arg; m/z = 70), lysine (Lys; m/z = 70, 84), isoleucine 
(Ile; m/z = 86), methylleucine (MeLeu; m/z = 100), and 
methylhomotyrosine (MeHTyr; m/z = 107, 164). Thus, 
five of the six amino acids present in the anabaenopeptins 
are identified, with the missing mass/charge entity cor-
relating with that of a phenylalanine (Phe) residue. This 
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also matches well with anabaenopeptin G, 7 in that its 
mass is only 2 Da higher than the new 13; it corresponds 
to the loss of a hydroxyl group from the tyrosine in posi-
tion 5, and an additional amino methylation on HTyr in 
position 3.
The higher mass fragments provide the sequence of the 
ring amino acids in 13. Thus, the m/z = 275 fragment 
shows that the Phe is joined to the MeLeu and the m/z = 
449 fragment shows that the Phe is also attached to the 
Lys, thus placing it in either position 3 or 6. The m/z = 
466 fragment can then be used to show that MeHTyr is 
attached to MeLeu as Phe is already attached to both Lys 
and MeLeu. This gives a final sequence of Ile-MeHTyr-
MeLeu-Phe, and supports the presence of an Ile-MeHTyr 
fragment at m/z = 305.
None of the fragments observed confirm the order in 
which the amino acids are present in the ring and whether 
Ile or Phe is located at position 3. The structure proposed 
as 13 has been constructed according to the sequences 
of presently known anabaenopeptins, where Phe is com-
monly seen at position 6 and an aromatic amino acid, 
such as HTyr, is always at position 4. This illustrates the 
limitation in characterizing secondary cyanobacterial 
Table 1. Amino acid sequence of the known Anabaenopeptinsa
Compound Mr 
(Da)
 1  3  4  5  6 Ref.
Anabaenopeptin A 843 Tyr Val HTyr MeAla Phe 20
Anabaenopeptin B 836 Arg Val HTyr MeAla Phe 20
Anabaenopeptin C 808 Lys Val HTyr MeAla Phe 25
Anabaenopeptin D 827 Phe Val HTyr MeAla Phe 25
Anabaenopeptin E 850 Arg Val MeHTyr MeAla Phe 26
Anabaenopeptin F 850 Arg Ile HTyr MeAla Phe 26
Anabaenopeptin G 908 Arg Ile HTyr MeLeu Tyr 18
Anabaenopeptin 
G*
929 Tyr Ile HTyr MeHTyr Ile 23
Anabaenopeptin H 922 Arg Ile HTyr MeTyr Ile 23
Anabaenopeptin I 759 Ile Val HTyr MeAla Leu 22
Anabaenopeptin J 793 Ile Val HTyr MeAla Phe 22
Anabaenopeptin T 865 Ile Val HTyr MeHTyr Ile 24
Anabaenopeptin 
KT864
864 HArg Ile HTyr MeAla Phe 27
Anabaenopeptin 
820
820 Arg Val HPhe MeAla Phe 12
Ferintoic Acid A 866 Trp Val HTyr MeAla Phe 28
Ferintoic Acid B 880 Trp Ile HTyr MeAla Phe 28
Nodulapeptin A 929 Ile Met(O
2
) HPhe MeHTyr Ser(Ac) 29
Nodulapeptin B 913 Ile Met(O) HPhe MeHTyr Ser(Ac) 29
Oscillamide B 868 Arg Met HTyr MeAla Phe 21
Oscillamide C 956 Arg Ile HTyr MeHTyr Phe 21
Oscillamide Y 857 Tyr Ile HTyr MeAla Phe 21
aNumbering for anabaenopeptins amino acids is as for 7 of Chart 2; D-Lys is 
omitted as it is always present in position 2 in the known anabaenopeptins.
Table 2. Fragment ions of anabaenopeptin 
906 observed by PSD.
m/z Sequence
70 Arg/Lys-related ion
84 Lys-Immonium ion
86 Ile-Immonium ion
100 MeLeu-Immonium ion
107 Tyr-side chain
112 Arg-Immonium ion
129 Arg-Immonium ion
164 MeHTyr-Immonium ion
175 Arg + 2H
201 CO + Arg
275 MeLeu + Phe + H
305 Ile + MeHTyr + H
449 Arg + CO + Lys + Phe - CO + 2H
466 MeHTyr + MeLeu + Phe + H
579 Ile + MeHTyr + MeLeu + Phe + H
594 Lys + Phe + MeLeu + MeHTyr + 2H
603 Arg + CO + Lys + Phe + MeLeu + H
707 Lys + Ile + MeHTyr + MeLeu + Phe 
+2H
907 M + H
Fig. 1. MALDI-TOF MS of a NZ lake sample.
Fig. 2. The MALDI-TOF PSD spectrum of m/z = 907 from Fig. 1.
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metabolites by MALDI-TOF MS as, at times, the com-
plete structure cannot be elucidated and stereochemistry 
can never be deduced. Ultimately, full characterization of 
these novel compounds requires purification and NMR 
spectroscopic investigations.
The screening of cyanobacterial extracts for oligopeptides 
by MALDI-TOF MS is a very powerful technique that 
can lead to the discovery of new compounds. It is simple, 
quick and inexpensive. Its use requires only a minute 
amount of sample that gives a rapid assessment of the 
presence or absence of novel metabolites.
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Dates of Note
April 22 marks the 150th anniversary of development of the 
fused salt electrolysis for commercial production of aluminium 
by Martin Killani.
Born on 27 Apr 1913, Philip Hauge Abelson was the US physi-
cal chemist who proposed the gas diffusion process for separat-
ing 235U from 238U, which was essential to the development of 
the atomic bomb. Also on this day (in 1896) was born Wallace 
Hume Carothers, the discovered of nylon.
Joel H. Hildebrand died on 30 Apr 1983. His monograph Solu-
bility (1924; later editions, Solubility of Non-Electrolytes) was 
the classic reference for almost a half century.
John William Draper, the English-American chemist who 
pioneered in photochemistry, was born on 5 May 1811. He 
recognized that light initiated chemical reactions as molecules 
absorbed light energy.
May 15 marks the 150th anniversary of the death of 1858 Robert 
Hare, the American chemist who devised the first oxyhydrogen 
blowpipe for the purpose of producing great heat. He melted 
sizeable quantities of platinum with this. His device is the pre-
cursor to the modern welding torch.
René-Just Haüy, the French mineralogist who founded of the 
science of crystallography through his discovery of the geomet-
rical law of crystallization, died on 1 Jun 1822. In 1781, he saw 
an accidentally dropped calcite crystal break into rhombohedral 
pieces. Deliberately breaking various forms of calcite, he found 
the same result, concluding that all the molecules of calcite have 
the same form and it is only how they are joined together that 
produces different gross structures. He suggested that other 
minerals should show different basic forms. His theory predict-
ed the correct angles of crystal faces in many cases.
June 19 is the 225th anniversary of the birth of Fredrich Wil-
helm Sertürner, the discoverer of morphine.
Richard Buckminster Fuller died on July 1 1983. He was the 
US engineer/architect who developed the geodesic dome.
Amedeo Avogadro published his memoir about the molecular 
content of gases on July 11 in 1811.
